September 6, 2023analysis, business, cannabis, cbd, compliance, consumer, cultivation, Epidiolex, EU, European, extraction, farm bill, FDA, Federal, FSA, government, growing, GW Pharma, industry, international, laboratories, laboratory, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, product, Quality, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, UK, union, United Kingdom

The CBD Regulatory Environment in Europe: Part 3

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part […]

February 28, 2023cbd, EU, hemp, Italy, KanaVape, Lazio, legalization, medical cannabis, military, News, world

Italian Court Rules Hemp Flowers, Leaves are Not Narcotics

A ruling by an Italian court earlier this month represents a huge break for the country’s hemp and CBD industry.  The decision […]

January 5, 2023analysis, analytics, Bloomwell, business, Business Analysis, C-suite, CANADA, canadian, cannabis, capital, capitalist, cbd, compliance, consumer, cultivation, dispensary, EU, europe, European, export, extraction, Federal, finance, financing, German, Germany, government, growing, import, income, industry, international, invest, investing, investment, law, leadership, legal, legalization, legalize, legislation, leverage, license, Luxembourg, Malta, marijuana, market, medical, opportunities, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, Soapbox, state, statement, Tilray, VC, venture

Investment Strategies for Entering the European Cannabis Market

For U.S. venture capitalists (VCs), the burgeoning European cannabis market provides opportunities to break into the industry on the heels of adult-use […]

July 7, 2022additive, analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, consumer, data, derived, dietary, drug, Edibles & Processing, EFSA, EU, europe, extraction, FDA, Federal, food, Gendel Food Safety, government, gras, growing, hemp, industry, international, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, New, novel, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, review, safety, state, Steven Gendel, test, Testing, thc, US

CBD Safety in Edibles: What Regulators are Thinking

Despite the popularity of cannabidiol (CBD) infused edibles among consumers there are storm clouds on the horizon for this market. The potential […]

May 11, 2022access, analysis, analytics, Aurora, business, Business Analysis, cannabis, cbd, compliance, Concentrates & Extracts, consumer, Denmark, EU, europe, export, Federal, GMP, government, growing, import, industry, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Odense, patient, product, Product Development, Quality, regulation, regulations, regulatory, safety, thc, U.K., UK, United Kingdom

Aurora Launches New Product Line in UK

Aurora Cannabis announced today that they will be launching a new product line for patients in the United Kingdom. The Berlin-based company […]

January 20, 2022analysis, analytics, Aphria, business, Business Analysis, CANADA, canadian, cannabis, Cannin, Cannin Commentary, cbd, commentary, compliance, cultivation, Cultivation & Growing, Dispensaries & Retail, dispensary, earnings, EBITDA, EU, europe, European, export, extraction, Federal, finance, financial, German, government, growing, holdings, import, industry, investing, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, product, Product Development, Q2, Quality, quarter, recreational, regulation, regulations, regulatory, report, reporting, results, retail, revenue, second, state, thc, Tilray

Is Tilray Stock a Buy Post Fiscal Q2 Results?

Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of 2022 results last week. The company reported net revenue of $155 […]

April 29, 2021analysis, analytics, API, business, Business Analysis, CANADA, cannabis, compliance, cultivation, dispensary, England, EU, EU-GMP, europe, European, expansion, export, Federal, Germany, global, GMP, government, growing, Holland, import, industry, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Netherlands, north america, Portugal, product, Quality, recreational, referendum, regulation, regulations, regulatory, retail, safety, spain, state, strict, test, thc, trade, U.K., U.N., United States, WHO

European Cannabis is Starting to Look Like the US Market 10 Years Ago

As the cannabis industry — now estimated to be worth more than USD 200 billion — continues to erupt around the world, […]

January 22, 2021analysis, analytics, Berlin, book, business, Business Analysis, CANADA, canadian, cannabis, CannaList EU, cbd, compliance, consumer, DACH, Eruopean, EU, europe, export, Federal, German, Germany, government, green, Green II, growing, Holland, import, industry, international, Israel, law, legal, legalization, legalize, legislation, Marguerite Arnold, marijuana, market, medical, medicine, patient, prescribe, prescription, product, reform, regulation, regulations, regulatory, safety, spain, Spreading Like Kudzu, state, Switzerland, thc, United States

New Book On Cannabis Describes A Global Market In Transition

Editor’s Note: This piece is an excerpt from Marguerite Arnold’s Green II: Spreading Like Kudzu. Click here to buy the book. THC […]

December 19, 2020acquire, acquisition, analysis, analytics, Aphria, billions, Brewing, business, Business Analysis, CANADA, canadian, cannabis, cbd, CEO, chairman, company, compliance, consumer, cultivation, distribute, distribution, equity, EU, europe, expansion, export, extraction, Federal, finalize, Germany, global, government, growing, import, Inc., industry, international, invest, investing, Irwin Simon, law, Leamington, legal, legalization, legalize, legislation, license, marijuana, market, merge, merger, millions, NASDAQ, new york, NY, Portugal, price, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, reverse, Seattle, shares, stock, strategies, strategy, SweetWater, thc, Tilray, Toronto, trading, U.S., United States, USA, value, Vancouver

Aphria & Tilray Merger Creates World’s Largest Cannabis Company

On December 16, 2020, Aphria Inc. (TSX: APHA and Nasdaq: APHA) announced a merger with Tilray, Inc. (Nasdaq: TLRY), creating the world’s […]

December 17, 20201, 19, 2020, 2021, 4, adult use, analysis, analytics, ballot, Biden, business, Business Analysis, CANADA, canadian, cannabis, cbd, commission, compliance, consumer, Coronavirus, court, COVID, COVID-19, cultivation, Denmark, deschedule, EC, economy, election, EU, Euro, europe, European, export, extraction, Federal, German, Germany, global, globe, government, growing, Holland, I, import, industry, initative, international, IV, law, legal, legalization, legalize, legislation, license, Luxembourg, marijuana, market, measure, medical, medicine, pandemic, policies, policy, Portugal, product, Quality, Recommendations, recreational, referendum, regulation, regulations, regulatory, reschedule, rescheduled, retail, safety, schedule, scheduling, spain, state, test, Testing, thc, UN, union, United Nations, vote, WHO, world, World Health Organization, worldwide

The 2020 Global Cannabis Regulatory Roundup

As a strange year heads to a final, painful finish, there have been some major (and some less so) changes afoot in […]